$GILD Company News Investors warm up to Gilead's test

New Post Public Reply Private Reply Replies (0) Message Board

Dec 21, 2013 at 4:37 PM

$GILD Company News

Investors warm up to Gilead's test results; shares climb 5% by close 4:49 p.m. Dec. 18, 2013 - Russ Britt
Twitter hits record; Campbell, Starbucks head south 4:25 p.m. Dec. 10, 2013 - Sue Chang
Speculators should retain a flexible approach 1:41 p.m. Dec. 4, 2013 - The Trading Deck
Nasdaq’s climb reflects vast shifts in global economy 10:19 a.m. Nov. 27, 2013 - Dan Strumpf
Nasdaq makes first close above 4,000 in 13 years: stock market live blog recap 5:03 p.m. Nov. 26, 2013 - blogs.marketwatch.com
AbbVie shares up on Hepatitis C results, but gains may be muted 11:49 a.m. Nov. 18, 2013 - Russ Britt
Dan Loeb ups stake in FedEx, Google, trims Yahoo 5:41 p.m. Nov. 14, 2013 - Sital S. Patel
Selling in growth-stock leaders continues 11:23 a.m. Oct. 31, 2013 - The Trading Deck
LinkedIn, Yelp decline; Baidu rallies after hours 5:14 p.m. Oct. 29, 2013 - Wallace Witkowski
Gilead profit up 17% as HIV drugs top sales growth 4:07 p.m. Oct. 29, 2013 - MarketWatch.com
Gilead shares rise 1% in late trading 3:59 p.m. Oct. 29, 2013 - Laura Mandaro
Earnings season focus shifts to revenue, capex 8:53 a.m. Oct. 27, 2013 - Wallace Witkowski
Healthcare stocks fall from first place in race for year's best-performing sector 2:32 p.m. Oct. 24, 2013 - blogs.marketwatch.com
In focus: Overbought conditions abound 7:21 p.m. Oct. 23, 2013 - Lawrence G. McMillan
Best Buy tops S&P 500; Netflix snaps losing streak 3:21 p.m. Oct. 10, 2013 - Sue Chang
Best Buy, Gilead Sciences lead S&P 500 gainers 3:05 p.m. Oct. 10, 2013 - Polya Lesova
Gilead, Acura stand out on up day for stocks, Quest tumbles 10:27 a.m. Oct. 10, 2013 - Russ Britt
Gilead ends leukemia study after positive results 4:10 p.m. Oct. 9, 2013 - MarketWatch.com
Citrix, Ruby Tuesday shares fall after hours 4:06 p.m. Oct. 9, 2013 - Wallace Witkowski
10 popular health-care stocks among hedge funds 11:34 a.m. Sept. 4, 2013 - Insider Monkey

2 Big Biotechs Moving Up On News 12:10 p.m. Dec. 20, 2013 - Seeking Alpha
Cramer's Mad Money - Themes That Will Work For 2014 (12/19/13) 6:23 a.m. Dec. 20, 2013 - Seeking Alpha
Jim Cramer's Top Stock Picks: AAPL CAT CX VMC CELG GILD 6:00 a.m. Dec. 20, 2013 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Some 'Buys' for the New Year 8:22 p.m. Dec. 19, 2013 - TheStreet.com
Positive Data on Gilead's Sovaldi - Analyst Blog 5:20 p.m. Dec. 19, 2013 - Zacks.com
Stock Market News for December 19, 2013 - Market News 10:06 a.m. Dec. 19, 2013 - Zacks.com
Cowen Forecasts Top 10 Potential Biotech Surprises for 2014 7:37 a.m. Dec. 19, 2013 - 247WallSt.com
Trade of the Day: Gilead Sciences (GILD) 4:08 a.m. Dec. 19, 2013 - InvestorPlace.com
Gilead's Sovaldi Holds Promise - Analyst Blog 4:30 p.m. Dec. 18, 2013 - Zacks.com
Gilead's Next Hepatitis C Drug A Hit In Trials 11:32 a.m. Dec. 18, 2013 - Investors Business Daily
Enanta falls after Gilead HCV data 10:56 a.m. Dec. 18, 2013 - Seeking Alpha
Gilead Offers Strong Data on Hepatitis C Treatment 10:12 a.m. Dec. 18, 2013 - WSJ.com
Gilead releases positive data from sofosbuvir/ ledipasvir HCV trials 9:30 a.m. Dec. 18, 2013 - Seeking Alpha
Waiting for a Signal From Gilead 9:00 a.m. Dec. 18, 2013 - RealMoney.com
Today's Pre-Market Trading Very Positive For Gilead (GILD) 8:58 a.m. Dec. 18, 2013 - TheStreet.com
Why Investors Are Writing Off Infinity Pharma 8:00 a.m. Dec. 18, 2013 - TheStreet.com
Piper Jaffray Top Stocks to Buy for 2014 7:44 a.m. Dec. 18, 2013 - 247WallSt.com
Gilead Sciences Inc (GILD): Today's Featured Drugs Laggard 5:06 p.m. Dec. 17, 2013 - TheStreet.com
Label of Gilead's Complera Expanded - Analyst Blog 12:00 p.m. Dec. 16, 2013 - Zacks.com
Gilead Announces Health Canada Notice of Compliance for Sovaldi for Treatment of Chronic Hepatitis C 7:39 a.m. Dec. 16, 2013 - benzinga.com

Obesity Stock Plays Standing Out from the Crowd 10:04 a.m. Dec. 20, 2013 - ACCESSWIRE
Gilead Sciences Tops List of California's Most Honored Companies in Institutional Investor's All-America Executive Team Ranking 8:00 a.m. Dec. 19, 2013 - Marketwire
Gilead Announces SVR12 Rates From Three Phase 3 Studies Evaluating a Once-Daily Fixed-Dose Combination of Sofosbuvir and Ledipasvir for Genotype 1 Hepatitis C Patients 8:30 a.m. Dec. 18, 2013 - BusinessWire
FDA Consents, Pending Acquisition Approvals, Program Deployments, and Stock Movements - Research Report on Gilead, Elan, Agilent, Alkermes and Hospira 8:00 a.m. Dec. 18, 2013 - PR Newswire
Critical Insider Analysis: MGM Resorts International, Groupon Inc, Gilead Sciences, Barrick Gold Corporation 9:30 a.m. Dec. 17, 2013 - ACCESSWIRE
FDA Approvals, Dividends, Promoting Diversity, Result Publications and Acquisitions - Research Report on Gilead, St. Jude Medical, Cigna, Pharmacyclics, and LifePoint 8:00 a.m. Dec. 17, 2013 - PR Newswire
Health Canada Issues Notice of Compliance for Sovaldi(TM) (Sofosbuvir) for the Treatment of Chronic Hepatitis C 8:30 a.m. Dec. 16, 2013 - BusinessWire
U.S. FDA Approves Gilead's Once-Daily Single Tablet HIV-1 Regimen Complera(R) for Patients Switching from a Stable Regimen 4:30 p.m. Dec. 13, 2013 - BusinessWire
HealthStat Rx: Curing Hepatitis C (HCV) With Confidence 10:07 a.m. Dec. 12, 2013 - BusinessWire
Here to Track Insider Trading of Gilead Sciences, Microsoft, Halliburton 8:55 a.m. Dec. 11, 2013 - PR Newswire
Clinical Study Results, Stock Price Movements, and Acquisitions - Research Report on Gilead, Life Technologies, Jazz Pharmaceuticals, CSI, and Smith & Nephew 8:00 a.m. Dec. 11, 2013 - PR Newswire
Final Hour Buzz: Gilead Sciences, MannKind Corporation, Facebook Inc, Tiger Oil and Energy 2:46 p.m. Dec. 10, 2013 - ACCESSWIRE
Interest Stock Analysis: Gilead Sciences, Acura Pharmaceuticals, Barnes & Noble, Micron Technology 11:00 a.m. Dec. 9, 2013 - ACCESSWIRE
Stock Price Updates, FDA 510(k) Clearances, Conference Presentation and Resignations - Research Report on Gilead, Oculus Innovative Sciences, ARCA biopharma, Arena Pharma, and Tonix Pharma 8:00 a.m. Dec. 9, 2013 - PR Newswire
Gilead Announces Pivotal Phase 2 Data for Idelalisib in Refractory Indolent Non-Hodgkin's Lymphoma 6:00 p.m. Dec. 8, 2013 - BusinessWire
Gilead Announces Interim Phase 2 Results for GS-9973 in Previously Treated Chronic Lymphocytic Leukemia 6:30 p.m. Dec. 7, 2013 - BusinessWire
U.S. Food and Drug Administration Approves Gilead's Sovaldi(TM) (Sofosbuvir) for the Treatment of Chronic Hepatitis C 4:19 p.m. Dec. 6, 2013 - BusinessWire
Gilead Sciences to Present at the NASDAQ OMX 30th Investor Program on Tuesday, December 3 5:00 p.m. Dec. 2, 2013 - BusinessWire
Critical Alerts For General Electric, Gilead Sciences, Morgan Stanley, Qualcomm, and Adobe Released By InvestorsObserver 9:31 a.m. Dec. 2, 2013 - PR Newswire
Market Expert Opinion: Gilead Sciences, NPS Pharma, InterMune, and Halozyme Therapeutics 8:40 a.m. Dec. 2, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mesirow Taps Shawn Beber as New CEO: Strategic Leap

Beber's Big Move: Mesirow Bets on Experience When a company's betting big on its next move, it goes for someone who's seen a storm or two. Enter Shawn Beber. Mesirow's new main guy. The firm isn't playing small potatoes with this hire. Fresh off a long gig at CIBC, Beber brings a hefty bag of tricks and a track record of navigating the high seas, none more impressive than...

Mind Meets Soul: Neuroscience and Spiritual Pathways

The Brain, Stress, and Spiritual Practices Ever tried to meditate and wondered if it actually does a number on your mind? Well, here comes Dr. Helen Lavretsky, who’s delving into the nitty-gritty of what happens up there when stress hits and spirituality steps in. This session on November 10 is bound to be a humdinger in the realm of science-meets-spirit. If you've ever...

WaterField's Starlink Case: Compact Yet Professional

Packing a Punch From Every Angle Listen, I've seen about every bag known to tech warriors, but WaterField's new Starlink Mini Go Case? It's turning some heads in the gizmo storage game. The folks at WaterField Designs, cooking out of San Francisco since '98, have whipped up something here that takes those clunky, military-style cases and swaps them for sleek, professional...

Capitol Pulse Survey Shows Staffers' Radical Shift

Generational Shifts and Ideological Alignments Among Congressional Aides There's no denying it, things are heating up on Capitol Hill—not in chambers, but in the offices. A fresh Capitol Pulse survey is shoving this under the spotlight, dissecting how congressional staffers’ political ideologies stack up against their bosses'. Conducted by CNCT and dissected by...

MPLX Reports Q3 2026 Results with 12.5% Distribution Hike

Another Distribution Hike: 12.5% Bump in Q3 Man, MPLX is at it again, boosting that quarterly distribution by a hefty 12.5%. That's three years running now, marking it up to $4.84 per unit on an annualized basis. In an industry where reliability sometimes feels like a relic, this kind of consistency is a sweet serenade to any income-focused investor's ears. "MPLX is...

Sunrate's Bold Move: New Payment Bond with Netstorming

Sunrate Joins Forces with Netstorming When two industry powerhouses shake hands, it's wise to sit up and listen. Sunrate, the global whiz in payment solutions, has linked arms with Netstorming, a tech-savvy pioneer in the travel sector. This ironclad partnership was announced at World Travel Market London 2026. Owners of travel businesses should take note: things are...

Multiconsult's Q3 2026 Results: A Gradual Rebound

Peering into the Q3 Crystal Ball When a company drops its quarterly results, it's like unveiling a new episode in an ongoing drama, and the Multiconsult ASA (Oslo: MULTI) saga is no exception. In their third quarter of 2026, the performance started to show signs of life following a somewhat sluggish run. While the numbers aren't sky-high, they're a solid indication that...

SRG DocketWatch: Tracking FCC Docs in Real-Time

I'll admit it—sometimes the FCC moves like molasses uphill. But keeping track of what they're up to? That's where the real challenge lies. Summit Ridge Group has tossed a lifeline for anyone who's got skin in the game with their new service, SRG DocketWatch. Why SRG DocketWatch Hits the Mark If you're poking your head into more than a few of those 21,000 FCC...

Saudi Tourism Steals the Spotlight at WTM London 2026

A Glimpse into Saudi's Ambitious Tourism Drive Ever feel like someone just decided to dominate the conversation at a global pow-wow? Well, that's the vibe Saudi Arabia brought to the World Travel Market (WTM) in London for 2026. With His Excellency Ahmed Al-Khateeb making headlines together with a mighty entourage of 37 tourism partners, the message was clear: Saudi...

Goodal Skincare Capitalizes on K-Beauty Craze at Costco

A Venture into American Retail Goodal, the darling of Korea's skincare scene, is staking its claim at Costco. This is no small feat, my friends. We're talkin' about a brand that's carved out a sweet niche with its Green Tangerine line. Now it's hitching its wagon to one of America's retail behemoths, known for its unique knack in beauty products. From Olive Young to...